AP NEWS
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Globe Newswire
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of DBVT, MKL, MAXR and UXIN

February 28, 2019

NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

DBV Technologies S.A. (NASDAQ: DBVT) Class Period: February 14, 2018 to December 19, 2018 Lead Plaintiff Deadline: March 18, 2019

According to the complaint, DBV Technologies S.A. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) DBV Technologies’ Biologics License Application (“BLA”) for Viaskin Peanut failed to provide the FDA with sufficient data on manufacturing procedures and quality controls; (2) consequently, DBV Technologies voluntarily withdrew the BLA for Viaskin Peanut; and (3) as a result, defendants’ statements about DBV Technologies’ business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the DBVT lawsuit: http://www.kleinstocklaw.com/pslra-1/dbv-technologies-s-a-loss-submission-form?wire=3

Markel Corporation (NYSE: MKL) Class Period: July 26, 2017 to December 6, 2018 Lead Plaintiff Deadline: March 12, 2019

During the class period, Markel Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s subsidiaries did not appropriately record loss reserves; (2) as a result, the loss reserves would need to be adjusted and/or restated; (3) these misleading accounting practices would lead to regulatory scrutiny and financial loss to investors; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Get additional information about the MKL lawsuit: http://www.kleinstocklaw.com/pslra-1/markel-corporation-loss-submission-form?wire=3

Maxar Technologies Inc. (NYSE: MAXR) Class Period: March 29, 2018 to January 7, 2019 Lead Plaintiff Deadline: March 15, 2019

Maxar Technologies Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Maxar improperly inflated the value of its intangible assets, among other accounting improprieties; (ii) Maxar’s highly-valued WorldView-4 was equipped with CMGs that were faulty and/or ill-suited for their designed and intended purpose; and (iii) as a result, Maxar’s public statements were materially false and misleading at all relevant times.

Get additional information about the MAXR lawsuit: http://www.kleinstocklaw.com/pslra-1/maxar-technologies-inc-loss-submission-form?wire=3

Uxin Limited (NASDAQGS: UXIN) Class Period: Pursuant and/or traceable to the Company’s Registration Statement and Prospectus issued in connection with the June 27, 2018 initial public offering Lead Plaintiff Deadline: April 12, 2019

The Registration Statement was materially false and misleading and omitted to state that: (1) Uxin was likely to stop providing complementary services such as inspections to its customers; (2) instead, Uxin would connect consumers to dealers who would provide such complementary services; (3) as a result, Uxin’s 2B business would be materially impacted; and (4) consequently, Defendants’ statements in the Registration Statement regarding Uxin’s business, operations, and prospects, were materially false and/or misleading.

Get additional information about the UXIN lawsuit: http://www.kleinstocklaw.com/pslra-1/uxin-limited-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:J. Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118 jk@kleinstocklaw.com Telephone: (212) 616-4899Fax: (347) 558-9665 www.kleinstocklaw.com